Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Biogen Idec (NQ: BIIB ) 231.58 +1.01 (+0.44%) Streaming Delayed Price Updated: 4:00 PM EDT, May 20, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Biogen Idec < Previous 1 2 3 4 5 6 7 8 9 ... 42 43 Next > How Is The Market Feeling About Biogen? Today 16:45 EDT Via Benzinga Large Cap Biopharmaceuticals Performance Today 15:00 EDT The biotech sector remains a laggard YTD as can be seen by the IBB. Via Talk Markets Wall Street Favorites: 3 Biotech Stocks with Strong Buy Ratings for May 2024 May 17, 2024 With new innovation, millions of retiring baby boomers, and an increase in mergers, biotech stocks to buy have a good deal of upside ahead. Via InvestorPlace Tale Of Two Ionis-Partnered Neurology-Focused Early Stage Assets-Biogen Discontinues One, Decides Not To Exercise Licensing Option For Another May 16, 2024 Ionis Pharmaceuticals and Biogen have halted development of BIIB105 for ALS after Phase 1/2 study results showed no impact on key clinical outcomes. Via Benzinga Biogen and Ionis Announce Topline Phase 1/2 Study Results of Investigational Drug in Amyotrophic Lateral Sclerosis May 16, 2024 From Biogen Inc. Via GlobeNewswire The Analyst Landscape: 27 Takes On Biogen April 29, 2024 Via Benzinga Biogen Stock Continues Its 20% Sprint On A Twist In Alzheimer's Treatment May 15, 2024 The company is hoping to launch an under-the-skin version of its infusion, Leqembi. Via Investor's Business Daily Eisai Initiates Rolling Biologics License Application to US FDA for LEQEMBI® (lecanemab-irmb) for Subcutaneous Maintenance Dosing for the Treatment of Early Alzheimer’s Disease Under the Fast Track Status May 14, 2024 From Biogen Inc. Via GlobeNewswire Jim Cramer Likes Micron And Its CEO, Recommends Buying This Big Bank May 13, 2024 Jim Cramer recommends buying Micron, adding that he likes the company's CEO Sanjay Mehrotra. As for Fidelis? "Not a favorite." Via Benzinga 3 S&P 500 Stocks to Rival Nvidia’s 2023 Performance in the Second Half of 2024 May 11, 2024 Let’s explore three stocks that are well-positioned to rival Nvidia’s growth rates in the second half of 2024. Via InvestorPlace Topics Stocks Exposures US Equities Will Earnings Cheer Continue To Buoy Markets? Apple, Amazon, Pfizer, Coinbase Lead Flurry Of Q1 Reports This Week April 29, 2024 With the earnings season now halfway through, the percentage of S&P 500 companies reporting positive earnings surprises and the magnitude of earnings surprises were above their 10-year averages. Via Benzinga Topics Stocks Exposures US Equities These Analysts Revise Their Forecasts On Biogen After Q1 Results April 25, 2024 Via Benzinga Where Biogen Stands With Analysts April 11, 2024 Via Benzinga The 3 Most Undervalued Pharma Stocks to Buy in May 2024 May 09, 2024 Investors looking for good deals in the pharmaceutical industry should watch out for these three undervalued pharma stocks. Via InvestorPlace Why Is Nuvo Group (NUVO) Stock Up 200% Today? May 06, 2024 Although prenatal care specialist Nuvo Group saw its shares soar on Monday, NUVO stock faces skepticism over its SPAC merger. Via InvestorPlace Biogen Reports Progress on Corporate Responsibility Priorities May 02, 2024 From Biogen Inc. Via GlobeNewswire 7 Retirement Stocks to Buy at a 52-Week Low in April April 29, 2024 One of the best ways to keep your portfolio safe while generating income is with dividend-paying retirement stocks at 52-week lows. Via InvestorPlace Topics Retirement Exposures Pension Stock Market Rebounds; Tesla, Microsoft, Google, Meta, Chipotle, GE In Focus: Weekly Review April 26, 2024 Microsoft, Tesla, Google, GE and Chipotle were earnings winners. Meta was a notable loser. Via Investor's Business Daily Meta Platforms To Rally Around 14%? Here Are 10 Top Analyst Forecasts For Thursday April 25, 2024 Via Benzinga Why Biogen Stock Leaped Nearly 5% Higher Today April 24, 2024 The company came out swinging with its first set of quarterly earnings for this year. Via The Motley Fool Biogen/Eisai's Popular Alzheimer's Drug Leqembi Is Seeing Slow Adoption - Here's Why April 24, 2024 Discover the challenges facing Leqembi, the first Alzheimer's drug shown to slow progression. Skepticism among doctors and concerns about efficacy and costs hinder widespread adoption despite FDA... Via Benzinga Exposures Product Safety Biogen (BIIB) Q1 2024 Earnings Call Transcript April 24, 2024 BIIB earnings call for the period ending March 31, 2024. Via The Motley Fool Topics Earnings Exposures Financial Biogen's Leqembi Commercial Ramp-Up Modest But Up Ticking, Reports Mixed Bag Q1 Earnings April 24, 2024 Biogen reports Q1 results: adjusted EPS $3.67 (beat consensus), sales $2.29 billion (missed consensus). Leqembi launch uptake triples, Zurzuvae's early trends encouraging. Via Benzinga Looking Into Biogen's Recent Short Interest April 03, 2024 Via Benzinga Treasury Yields Rise, Tesla Jumps On Cheaper Model Pledge, Yen Plummets To 34-Year Lows: What's Driving Markets Wednesday? April 24, 2024 Rising Treasury yields have investors cautious despite positive news from the earnings season. The yield on the long-dated 30-year Treasury bond has surged to 4.79%. It’s on track to close at the... Via Benzinga Topics Bonds Exposures Debt Markets BIIB Stock Earnings: Biogen Beats EPS, Misses Revenue for Q1 2024 April 24, 2024 BIIB stock results show that Biogen beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. Via InvestorPlace Two Notable Biogen Drugs Walloped Sales Forecasts. Will It Be Enough To Reverse Biogen Stock's Decline? April 24, 2024 Biogen shares have lost nearly 40% of their value since last June. Could two key sales beats help revive shares? Via Investor's Business Daily Topics Earnings Exposures Financial Nasdaq Futures Get A Lift From Tesla, Texas Instruments Earnings: Analyst Points To Key Catalyst For Boosting Rally April 24, 2024 Nasdaq and S&P 500 futures signaled a higher open on Wednesday, thanks to upbeat guidance from EV giant Tesla, Inc. (NASDAQ:TSLA) and semiconductor m Via Benzinga 10 Health Care Stocks With Whale Alerts In Today's Session April 09, 2024 Via Benzinga Can Magnificent 7 Help Script Market Turnaround? Earnings Pick Up Pace With Microsoft, Meta, Alphabet And Tesla Expected This Week April 21, 2024 Corporate profit growth rose in Q3 2023 and is expected to continue in Q1. Via Benzinga < Previous 1 2 3 4 5 6 7 8 9 ... 42 43 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.